MPharma on the mic: cut CAC in half
Inside the numbers: what it means for operators building in $Nairobi.
- How Uganda's market shapes the outcome.
- What to watch next as the story develops.
- Why it matters now for founders — and who it affects first.
Inside the numbers: what it means for operators building in $Nairobi.
- How Uganda's market shapes the outcome.
- What to watch next as the story develops.
- Why it matters now for founders — and who it affects first.
For anyone building in podcasts, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
The numbers behind mPharma's latest move tell a sharper story than the press release.
The team's bet is simple: cut CAC in half without burning the runway that the IFC just extended.
Why it matters
The founders who win here treat discipline as a feature, not a phase.
Strip away the hype and you're left with a practical question about unit economics that every operator faces.
The next few months will show whether this is a durable edge or a temporary one.
What to watch next
- How the a lending product performs outside the launch market.
- Whether mPharma can hold margins while it chases a 3x return.
- How Uganda's regulators respond over the next two quarters.
The bet is placed. The market will settle it soon enough.
